(Q48034814)

7 February 2018

title

Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? (English)

1 reference

7 February 2018

1 reference

1

1 reference

7 February 2018

Valentina Citi

Valentina Citi

3

0 references

Francesca Bellagambi

Francesca G Bellagambi

5

0 references

Lara Testai

Lara Testai

2

0 references

Vincenzo Calderone

Vincenzo Calderone

8

0 references

Silvia Ghimenti

6

Silvia Ghimenti

1 reference

7 February 2018

author name string

Alice Marino

4

1 reference

7 February 2018

Maria C Breschi

7

1 reference

7 February 2018

publication date

25 November 2013

1 reference

7 February 2018

published in

Vascular Pharmacology

1 reference

7 February 2018

volume

60

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

32-41

1 reference

7 February 2018

The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulphide: novel opportunity for drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide mediates the vasoactivity of garlic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Cysteine-activated hydrogen sulfide (H2S) donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Pharmacological profile of a novel H(2)S-releasing aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

1,4-Benzothiazine ATP-sensitive potassium channel openers: modifications at the C-2 and C-6 positions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide and cell signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Interaction of hydrogen sulfide with ion channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Modulation of ion channels by hydrogen sulfide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

4-aminopyridine-sensitive K+ channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.11.003

10.1016/J.VPH.2013.11.003

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

24287004

1 reference

7 February 2018